The agreement includes $25 million in upfront and near-term payments and could bring Caris up to $1.1 billion in milestone payments tied to research, development and sales, the companies said. Sign up ...

A flurry of dealmaking hasn’t let up as 2025 comes to a close, with Roche subsidiary Genentech getting in on the action and crafting a multi-year cancer collaboration with Caris Life Sciences.

Caris Life Sciences (CAI) has quietly outperformed in the past month, climbing about 16% even as its past 3 months remain negative. This setup invites a closer look at what investors may be repricing.

Caris Life Sciences Inc. (NASDAQ:CAI) is one of the best biotech stocks to buy according to Wall Street analysts. On December 4, 2025, Caris Life Sciences (NASDAQ:CAI) announced it will present 19 ...

A woman who crashed her car into a Center Line home and injured a 9-year-old girl had a high level of alcohol in her system, according to Macomb County prosecutors. A six-month misdemeanor charge of ...

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Imagine a world where every cancer patient can hear the words: “don’t worry, we have a personalized treatment that can help your type of disease.” Caris Life Sciences, headquartered in Irving, Texas, ...

About Caris Life Sciences Inc. Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.